CLINICAL_TRIALS withdrawal · 2017-06-01

Clinical Trial Update: Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus [EARLY_Phase 1]

A Phase 1 study evaluating the effects of DPP-4 inhibition on calcium and bone metabolism in Type 2 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Missouri-Columbia | Conditions: Type 2 Diabetes | EARLY_Phase 1 | Status: WITHDRAWN